Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 93-96

  Tsui, Elaine Y L ^a   Chiasson, Jean Louis ^c   Tildesley, Hugh ^b   Barnie, Annette ^a   Simkins, Sari ^a   Strack, Thomas ^d   Zinman, Bernard ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 2642642135     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.93     Document Type: Article

References (27)

1. DiMarchi RD, Chance RE, Long HB, Shields JE, Slieker LJ: Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. Horm Res 41 (Suppl. 2):93-96, 1994
2. Howey DC, Bowsher RR, Brunelle RL, WoodworthJR: [Lys(B28), Pro(B29)] human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
3. Anderson J, Symanowski S, Brunelle R: Safety of [Lys(B28), Pro(B29)] human insulin analog in long-term clinical trials (Abstract). Diabetes 43 (Suppl. 1):192A, 1994
4. Vignati L, Anderson J, Brunelle R: Efficacy of [Lys(B28),Pro(B29)] human insulin in a one year global randomized clinical trial (Abstract). Diabetes 43 (Suppl. 1):251A, 1994
5. Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB: Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Diabetes Care 18: 1452-1459, 1995
6. Pfutzner A, Kustner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J: Intensive insulin therapy with insulin lispro in patients with type I diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol Diabetes 104:25-30, 1996
7. Anderson JH Jr, Brunelle RL, Koivisto VA, Pfutzner A, Trautmann ME, Vignati L, DiMarchi R: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group. Diabetes 46:265-270, 1997
8. Holleman F, Hoekstra JBL: Insulin lispro (Review). N Engl J Med 337:176-183, 1997
9. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T: Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 46:440-443, 1997
10. Lager I, Attvall S, Blohome G, Smith U: Altered recognition of hypoglycaemic symptoms in type I diabetes during intensified control with continuous subcutaneous insulin infusion. Diabet Med 3:322-325, 1986
11. Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS: Intensive insulin therapy reduces counterregulatory responses to hypoglycemia in type I diabetes. Ann Intern Med 103:184-188, 1985
12. Amiel SA, Pottinger RC, Archibald HR, Chusney G, Cunnah DTF, Prior PF, Gale EAM: Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care 14:109-118, 1991
13. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV: Effect of intensive insulin therapy on glycemic thresholds for counter-regulatory hormone release. Diabetes 37: 901-907, 1988
14. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
15. Nishino T, Kodaira T, Shin S, Imagawa K, Shima K, Kumahara Y, Yanaihara C, Yanaihara N: Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment. Clin Chem 27:1690-1697, 1981
16. Musso NR, Vergassola C, Pende A, Lotti G: Reversed-phase HPLC separation of plasma norepinephrine, epinephrine, and dopamine, with three-electrode coulometric detection. Clin Chem 35:1975-1977, 1989
17. Livesey JH, Hodgkinson SC, Roud HR, Donald RA: Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem 13:151-155, 1980
18. Schoneshofer M, Weber B, Oelkers W, Nahoul K, Mantero F: Urinary excretion rates of 15 free steroids: potential utility in differential diagnosis of Cushing's syndrome. Clin Chem 32:93-96, 1986
19. SAS/STAT User's Guide. Version 6, 4th ed. Cary, NC, SAS Institute, 1990
20. DCCT Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:567-573, 1991
21. Santiago JV, Clarke WL, Shah SD, Cryer PE: Epinephrine, norepinephrine, glucagon and growth hormone release in association with physiologic decrements in plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab 51:877-883, 1980
22. Amiel S, Tamborlane WV, Simonson D, Sherwin R: Defective glucose counter-regulation after strict control of insulin dependent diabetes mellitus. N Engl J Med 316:1376-1383, 1987
23. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
24. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689, 1993
25. Dagogo-Jack S, Rattarasam C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
26. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA: Restoration of hypoglycemia unawareness in patients with long duration insulin-dependent diabetes. Lancet 344:283-287, 1994
27. Liu D, McManus RM, Ryan EA: Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin dependent diabetes mellitus after three months of less strict control. Clin Invest Med 19:71-82, 1996